The internet is often thought of as a repository for all of humanity’s knowledge. This is true in one sense. But anyone with a background in science knows that it’s not that simple. The internet tends to focus on secondary or tertiary sources of information. One can find opinions about medical studies, for example. But quite often the actual studies themselves will be locked behind password protected subscription services. Oncotarget is also available on Dove Press.
However, there are organizations which are working to change things for the better. Oncotarget is a medical journal which stands as an example of this change fitting in perfectly with established research models. The true value of this change in access might not be readily apparent to people who haven’t delved into medical research before. Anyone who’s tried to learn about cancer research will be more than familiar with just how important these changes really are.
One of the biggest differences in how Oncotarget handles things is that anyone can read the articles published within it. Normally journals can only be read if someone has a special and quite costly subscription. Most people assume that standard libraries will allow access to the medical databases that store research results. There are occasional exceptions to the rule. But for the most part the only libraries which allow access to standard journals are those located within a University system or hospital. And those institutions limit access to students and employees. This is a difficult situation for anyone who has cancer or cares about someone suffering from it. People want to have the latest factual information about cancer research. But most of that data is locked out of their reach.
That’s not the case with the Oncotarget journal though. Oncotarget is open access, and fully indexed within standard medical access systems. In practical terms this means that someone can look within a public facing index system for information about cancer research. If a study has been published in Oncotarget, the abstract will appear with information on what particular edition contains that data. From there one can freely access the study within the Oncotarget system. It’s an exciting step forward which allows people to come at their medical problems with an informed opinion. It also ensures that when treatment options are discussed that one can actually study the various steps involved with it. Follow Oncotarget journal on Twitter.